Taigen Biopharmaceuticals Holdings Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taigen Biopharmaceuticals Holdings Ltd with three other
companies in this sector in Taiwan:
Foresee Pharmaceuticals Co Ltd
sales of 26.04 million Taiwanese Dollars [US$857,105.12 ]
(35.88 million Taiwanese Dollars [US$1.18 million]
of which 91%
was Sales), and
Twi Biotechnology Inc
(25.84 million Taiwanese Dollars [US$850,554.04 ]
of which 100%
was Sales Income).
Sales fell dramatically in 2018:
Taigen Biopharmaceuticals Holdings Ltd reported sales of 29.62 million Taiwanese Dollars (US$975.02 thousand)
December of 2018.
decrease of 94.6%
versus 2017, when the company's sales were 553.21 million Taiwanese Dollars.
Contributing to the drop in overall sales was the 95.1% decline
in Medical Development, from 550.66 million Taiwanese Dollars to 27.04 million Taiwanese Dollars.
However, these declines were partially offset by the increase in sales of
Medical Consultance (up 1.2% to 2.58 million Taiwanese Dollars)